Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mesa Laboratories announced its acquisition of Gyros Protein Technologies, a differentiated leader in biopharmaceutical development solutions. The transaction combines Mesa's operational excellence with Gyros' innovative product portfolio and global talent, expected to drive organic growth and deliver accretion to Mesa across multiple financial metrics.
investor_presentation
50 Pages
Philip Morris International
investor_presentation
Aegis Logistics Limited
Retail Opportunity Investments Investor Presentation — December 2021
investor_presentationinvestor_presentation
20 Pages
Retail Opportunity Investments Corporation